Entity
Description
  • Value proposition

    Embleema is the regulatory-grade health data platform to accelerate new drug discovery and release new treatments sooner

    Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project ARGOS). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects and tens of other clinical studies for pharmaceutical companies, biotechs and patient groups. More than half of the top 10 Investigational sites in the US use our platform: John Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St Louis, Cornell and many others also such as Mayo Clinic, Yale, Georgetown.

    Blockchain, Healthcare Technology, Electronic Medical Records, healthcare, Clinical Research, Clinical Trials, Medicine, Technology, Genomics, Bioinformatics, and Precision Medicine

  • Embleema - Redefining Observational Research for Precision Medicine

    Embleema’s platform accelerates observational research, connecting patients and researchers to advance precision medicine with seamless data collection and compliance.

  • https://www.embleema.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Techstars Iowa Accelerator
Techstars Iowa Accelerator
Startup accelerator & VC, Venture Capital & Private Equity
Techstars Iowa Accelerator
Startup accelerator & VC, Venture Capital & Private Equity
Other

4 Oct 2019


Région Nouvelle-Aquitaine
Région Nouvelle-Aquitaine
National and local authorities, Government Administration
Région Nouvelle-Aquitaine
National and local authorities, Government Administration
Other

2 Jul 2019


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

7 Nov 2018


STATION F
STATION F
Startup accelerator & VC, Software Development
STATION F
Startup accelerator & VC, Software Development
Not capitalistic
Not partnership
Event

3 Oct 2018


Capgemini
Capgemini
Consulting, IT Services and IT Consulting
Capgemini
Consulting, IT Services and IT Consulting
Not capitalistic
Partnership
Event

20 Dec 2018


IBM
IBM
IT services, IT Services and IT Consulting
IBM
IT services, IT Services and IT Consulting
Other

26 Apr 2019


Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Not event

4 Dec 2018


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Event

8 Nov 2018


innov'a
innov'a
Non-profit Organizations
innov'a
Non-profit Organizations
Other

12 Nov 2018


Similar entities
Loading...
Loading...
Social network dynamics